Jobs
Cambridge, US; Mainz, Germany | full time | Job ID: 11146
About the role:
As an Associate Director of Investor Relations, you will be instrumental in shaping and executing BioNTech's communication strategy for the investment community. Your contributions will help elevate investor engagement and optimize company valuation, ensuring alignment with BioNTech’s mission to improve global health through oncology innovation. You will be part of a high-performing team, collaborating closely with senior leaders across diverse functions to build and refine BioNTech’s equity narrative.
In this visible and impactful role, you will foster trust internally and within the investment community, while showcasing our strategic vision, oncology pipeline, and long-term growth potential.
Your Contribution:
- Support and drive strategic initiatives to enhance communication and engagement with analysts and investors
- Track updates and generate insights from market activity, policy updates, financial trends, competitor landscape, and shareholder concerns to fine tune function’s investor engagement approaches
- Develop consensus estimates, shareholder assessments, and analytics approaches that shape meaningful engagements Internal
- Articulate the value of BioNTech’s oncology assets, technology platforms, and long-term growth potential through compelling equity narratives
- Inform a high-impact IR event calendar, including roadshows, investor and medical conferences, IR company events and quarterly updates
- Collaborate cross-functionally with leaders across R&D, medical, finance, corporate communications, commercial teams, legal teams, and policy experts
- Ensure compliance with legal, regulatory and industry standards in all communications and internal and external engagements
A Good Match:
- Bachelor’s degree required; with 6 plus years of relevant professional experience required; could include investor relations, corporate communications, corporate development, competitive intelligence, financial/business analytics/consulting, equity research or similar roles within biopharmaceutical space
- Strong quantitative expertise, including knowledge of business/financial modeling, financial reporting, or valuation techniques to empower IR’s ability to analyze and generate insights from broker and market data.
- Exceptional written/verbal communication skills for presenting complex topics clearly and concisely in various settings. Thrives in fast-paced working environments with ability to advance multiple projects simultaneously to tight deadlines.
- Meticulous attention to detail, and ability to independently deliver high-quality, accurate content and documents.
- Collaborative team player with proven ability to build strong relationships across functions and organizational levels.
Preferred qualifications: Advanced academic credentials (MBA or Masters Degree) and biopharmaceutical oncology experience.
Your Benefits:
It's our priority to support you:
- Your flexibility: flexible hours | vacation account
- Your growth: Digital Learning | Performance & talent development | leadership development | Apprenticeships | LinkedIn Learning
- Your value: Your voice at the table | Culture on an equal footing | Opportunities to shape & impact | Support for your full potential
- Your health and lifestyle: Company bike
- Your mobility: Job ticket | Deutschlandticket
- Your life phases: Employer-funded pension | Childcare
Apply now
- We look forward to your application!
Apply to our Cambridge, US; Mainz, Germany location by sending us your documents via our online form. For any questions, contact our talent acquisition team on: + 49 (0) 6131-9084-1291 (Monday-Friday from 1 PM to 3 PM CET).
Job ID 11146 (please always specify if you have any questions)
By submitting your application, you acknowledge that a background check will be conducted as part of the recruitment process in accordance with applicable laws and regulations. If you are considered for the position, BioNTech will conduct the background check through our service provider ‘Hire Right’. You will be informed accordingly by your BioNTech-Recruiter.
Total Views
0
Apply Clicks
0
Weekly mock applicants
0
Bookmarks
0
Similar jobs

Assistant Manager - TAX - National - TAX - GCR - ACR - Mumbai
EY ·

Commercial and Investment Bank Treasury Liquidity Analytics-Vice President
JPMorgan Chase · LONDON, LONDON, United Kingdom, GB

Financial Analysis Manager
Micron · 2 Locations

Plan Chief Financial Officer
Centene · 2 Locations

Vice President - Investment Management Risk Operations
Morgan Stanley · New York, New York, United States of America
About BioNTech

BioNTech
PublicBioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
1,001-5,000
Employees
Mainz that develops immunotherapies
Headquarters
$21.7B
Valuation
Reviews
4.0
10 reviews
Work-life balance
2.5
Compensation
3.8
Culture
4.2
Career
3.5
Management
3.2
75%
Recommend to a friend
Pros
Innovative and cutting-edge projects
Great team and collaborative environment
Excellent benefits and flexible schedule
Cons
Long working hours and high workload
Fast-paced and high-pressure environment
Management and communication issues
Salary Ranges
70 data points
Mid/L4
Mid/L4 · Project Manager
3 reports
$122,537
total per year
Base
$106,811
Stock
$9,411
Bonus
$6,316
$88,589
$172,342
Interview experience
1 interviews
Difficulty
3.0
/ 5
Duration
14-28 weeks
Interview process
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Panel Interview
5
Final Interview
6
Offer
Common questions
Behavioral/STAR
Technical Knowledge
Past Experience
Culture Fit
Problem Solving
News & Buzz
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily
Oncodaily
News
·
3d ago
BioNTech And Boehringer Trial Adds Dimension To Small Cell Lung Cancer Story - simplywall.st
simplywall.st
News
·
5d ago
Biontech prepares FDA application after strong phase II results in endometrial cancer - medwatch.com
medwatch.com
News
·
1w ago
BioNTech and DualityBio report positive data for trastuzumab pamirtecan - Clinical Trials Arena
Clinical Trials Arena
News
·
1w ago